BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26011821)

  • 1. Technology for deep brain stimulation at a gallop.
    Priori A
    Mov Disord; 2015 Aug; 30(9):1206-12. PubMed ID: 26011821
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Toft M; Dietrichs E
    Mov Disord; 2014 Feb; 29(2):275-6. PubMed ID: 23696136
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation for advanced Parkinson's disease.
    Rodriguez-Oroz MC
    Lancet Neurol; 2010 Jun; 9(6):558-9. PubMed ID: 20434404
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.
    Khan S; Mooney L; Plaha P; Javed S; White P; Whone AL; Gill SS
    Br J Neurosurg; 2011 Apr; 25(2):273-80. PubMed ID: 21344974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep-brain stimulation for Parkinson's disease.
    Okun MS
    N Engl J Med; 2012 Oct; 367(16):1529-38. PubMed ID: 23075179
    [No Abstract]   [Full Text] [Related]  

  • 8. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertainty, misunderstanding and the pedunculopontine nucleus: the exhumation of an already buried dispute.
    Mazzone P; Insola A; Valeriani M; Caliandro P; Sposato S; Scarnati E
    Acta Neurochir (Wien); 2012 Aug; 154(8):1527-9; author reply 1531-3. PubMed ID: 22588336
    [No Abstract]   [Full Text] [Related]  

  • 11. Pallidal vs subthalamic deep brain stimulation for Parkinson disease: winner and loser or a sharing of honors?
    Minguez-Castellanos A; Escamilla-Sevilla F
    Arch Neurol; 2005 Oct; 62(10):1642-3; author reply 1643. PubMed ID: 16216956
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
    Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa and subthalamic deep brain stimulation responses are not congruent.
    Zaidel A; Bergman H; Ritov Y; Israel Z
    Mov Disord; 2010 Oct; 25(14):2379-86. PubMed ID: 20824733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral subthalamic deep brain stimulation in Parkinson disease patients with severe tremor.
    Kim HJ; Jeon BS; Paek SH; Lee JY; Kim HJ; Kim CK; Kim DG
    Neurosurgery; 2010 Sep; 67(3):626-32; discussion 632. PubMed ID: 20647970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation in parkinson disease.
    Bernardo WM; Rubira C; Silvinato A
    Rev Assoc Med Bras (1992); 2019 May; 65(4):541-546. PubMed ID: 31066807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and deep brain stimulator placement.
    Deiner S; Hagen J
    Anesthesiol Clin; 2009 Sep; 27(3):391-415, table of contents. PubMed ID: 19825483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson disease: deep brain stimulation versus best medical therapy for PD.
    Brodsky MA; Nutt JG
    Nat Rev Neurol; 2010 Oct; 6(10):530-2. PubMed ID: 20927052
    [No Abstract]   [Full Text] [Related]  

  • 18. Is deep brain stimulation neuroprotective if applied early in the course of PD?
    Charles PD; Gill CE; Davis TL; Konrad PE; Benabid AL
    Nat Clin Pract Neurol; 2008 Aug; 4(8):424-6. PubMed ID: 18594505
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in deep brain stimulation for Parkinson disease: early and "asleep"?
    Ponce FA
    World Neurosurg; 2014 Jan; 81(1):6-8. PubMed ID: 24291370
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease.
    Pötter-Nerger M; Reich MM; Colebatch JG; Deuschl G; Volkmann J
    Mov Disord; 2012 Sep; 27(10):1268-75. PubMed ID: 22693156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.